Clinical Trial Update: A Trial to Compare Automated Lyumjev Delivery With Carbohydrate Counting, Qualitative Meal-size Estimation, and Meal Detection in Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing automated Lyumjev delivery with carbohydrate counting and meal estimation in Type 1 diabetes. Status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Lyumjev (insulin lispro)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Diabetes Mellitus, Type 1, Type 1 Diabetes | Phase 2 | Status: UNKNOWN